Blood Cancers Today Jan/Feb 2024 | Blood Cancers Today

Jan/Feb 2024

This issue of Blood Cancers Today includes a feature on mass spectrometry in managing plasma cell disorders; a Get to Know with Ching-Hon Pui, MD; an editor’s message from Thomas Martin, MD; and more.

Viewpoints

Editor's Message

Our 2024 Mission: Embrace Kindness, Share Knowledge, Be Part of SOHO

Features

News

Regulatory Actions

FDA Requests Boxed Warning Label on CAR-T Therapies Used to Treat Blood Cancers

FDA Lifts Partial Hold on Lacutamab Clinical Trial Program After Investigation

FDA Approves Label Update for Zanubrutinib for CLL

Label Update for Axi-Cel Approved by US FDA After ZUMA-7

Selinexor Added to China’s National Reimbursement Drug List

China’s NMPA Accepts sBLA for Relma-Cel Injection

FDA Grants Breakthrough Device Designation for Multicancer Early Detection Solution

State of the Art

SOHO State of the Art Updates and Next Questions: Acute Lymphoblastic Leukemia

News Roundup

Sylvester Research Group Develops New Tool for Predicting Myeloma Risk

STIMULUS-MDS1 Trial Compares Sabatolimab Plus HMAs Versus Placebo in Higher-Risk MDS

Is Early Intervention for Smoldering Multiple Myeloma Beneficial?

How Do Coping Strategies Impact Patients Prior to HSCT?

Meeting News

Baseline Immunologic State Affects CAR-T Cell Response in LBCL

Momelotinib Improves ‘Quality of Survival’ in Myelofibrosis

Combining Triplet with Molecularly Targeted Therapy Could Enhance MM Response

Real-World Data Show High Rate of Second Cancers After Polycythemia Vera Diagnosis

Luspatercept Is Effective for ESA-Naïve, Transfusion-Dependent, Lower-Risk MDS

Knowledge Hubs

Phase II Study: Mosunetuzumab Shows ‘Highly Encouraging Efficacy’ in Follicular Lymphoma

Dual Treatment Shows Promising Efficacy in Untreated Follicular Lymphoma

Epcoritamab Produces Promising Responses in Patients With Follicular Lymphoma

HemOnc Happenings

2024 ASH President Begins Term for Society

Hematologist-in-Training Honored with ASH Abstract Achievement Award

CR&T Lifetime Achievement Award Recognizes Lymphoma Researcher

Editorial Board

Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine

Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center

Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University

Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer